Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

Figure 2

Kaplan-Meier curves for median overall survival (OS) of colorectal cancer patients treated with irinotecan and cetuximab showing phosphorylated AKT expression (-------) and without phosphorylated AKT expression (———) in either primary tumours (A, 7.8 months vs. 26.7 months, p < 0.0001) or metastases (B, 6.1 months vs. 26.7 months, p < 0.0001).

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us